Navigation Links
InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
Date:8/30/2010

products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: restenosis, embolic showers, and late thrombosis. In addition to providing embolic protection and minimizing arterial injury, this promising technology can be an effective and uniform drug delivery mechanism with the help of the novel micron-level net for next generation drug eluting stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.

About Stent for Life:

There is indisputable scientific evidence that myocardial revascularization in patients with acute forms of coronary artery disease is life saving; it reduces mortality, rates of non-fatal reinfarction and stroke, as compared to the previous standard of care (pharmacological treatment, including thrombolytic therapy for STEMI).

The Stent for Life Initiative is a unique European platform for interventional cardiologists, government representatives, industry partners, patient groups and patients to work together and, by shaping the health care systems and medical practices, ensure that the majority of STEMI patients will have an equal access to the life saving indication of PCI.

The executive board is: Prof. Petr Widimsky, Co-Chairman; Dr. Jean Fajadet, Co-Chairman; Dr. William Wijns; Prof. Carlo di Mario; Prof. Nicolas Danchin; Prof. Steen D. Kristensen; Dr. Zuzana Kaifoszova; Marielle de la Torre.

The participating organizations are: EAPCI, EuroPCR, the ESC Working Group on Acute Cardiac Care and the National Cardiology Societies and/or National Working Groups for Interventional Cardiology (WGIC)

'/>"/>
SOURCE Inspire MD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
2. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
3. As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage
4. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
5. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
6. Missouri Becomes the Fourth State to Connect to Kentuckys Real-time Cold Medicine Tracking System
7. Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System
8. US Oncology Foundation Becomes Life Beyond Cancer Foundation
9. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
10. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
11. Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ...   10503), vorgestellt auf dem Jahrestreffen der ... PharmaMar teilt mit, dass Janssen Research ... multizentrischen Phase-3-Studie SAR3007 bekannt gegeben hat, ... (progression-free survival, PFS) mit Trabectedin (YONDELIS ® ...
(Date:6/1/2015)... 2, 2015 Amgen (NASDAQ: AMGN ... a Phase 1b study to evaluate the safety ... immunotherapy, in combination with Roche,s investigational anti-PDL1 therapy, ... triple-negative breast cancer and colorectal cancer with liver ... oncolytic immunotherapy designed to selectively replicate in tumors ...
(Date:6/1/2015)... June 1, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular ... highlights and financial results for the three months ... herein are in Canadian dollars unless otherwise stated. ... business strategies despite its limited financial resources," stated ...
Breaking Medicine Technology:PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 3PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 4PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 5PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5
... (Nasdaq: GNTA ) today announced financial results and progress,for ... noted,significant recent milestones, including:, -- ... -- New oral product, G4544, completes initial Phase ... -- Tesetaxel, a leading oral taxane, becomes new ...
... Committee Recommends FDA Approve Novel Anesthesia Drug to Reverse Muscle ... ... Schering-Plough,(NYSE: SGP ) today announced that the U.S. ... Support has recommended,sugammadex for approval. After reviewing data on the ...
Cached Medicine Technology:Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 2FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 3FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 4
(Date:6/2/2015)... Date: Thursday, June 4, 2015 , Time: 2 ... Broad Street, 4th floor, Philadelphia, Pa 19107 , ... will visit Philadelphia City Council to urge city leaders ... C in Philadelphia’s at-risk populations. , Foundation leaders and ... B United Philadelphia (HBUP), will join Hepatitis C Allies ...
(Date:6/2/2015)... June 02, 2015 While the movie ... of comic books, comic books themselves are stepping into ... Uniting Nations plans to produce educational comics in multiple ... Goals for Sustainable Development - an international effort to ... hunger, health, education, sustainable energy, inequality, climate change and ...
(Date:6/2/2015)... Join us for a new event in Westwood, ... Rhonda Martin , who overcame her brain aneurysm during the ... to raising awareness and funds for brain aneurysm research. ... that there will be one less case of someone suffering ... to join the 1st Anniversary Awareness Walk in Honor ...
(Date:6/2/2015)... June 02, 2015 Pacifica Graduate ... set up by current and former students to honor ... faculty member from 2002 until his death in 2013. ... and depth of feeling, as well as his passion ... capacities as an analyst, teacher, and writer were felt ...
(Date:6/2/2015)... June 02, 2015 “We want men to ... (UV) sun rays”, states Marta Phillips, owner of SunGrubbies.com, ... sun hats and sun accessories that work well for outdoor ... immediately evident. Sometimes sun damage can take up to thirty ... are prime areas for skin cancer to occur. That ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2
... HILLS, Mich., May 13 Fund-raising for disease,research got ... and,President Jim Press and his wife Suwichada presided as ... annual Promise Ball,in Dearborn, Mich., As part of ... presented to Cynthia and Edsel B. Ford II. The ...
... Encourages Women to ,Speak Up For Down There, During National ... ... Despite living in a society,that promotes images and icons of ... Dr. Sue Johannsen and even,former Supreme Court Justice Sandra Day O,Conner, ...
... post-university years can start out tough. The good news: ... study of almost 600 of its graduates (ages 20-29 ... seven years post-graduation and looked at how key events ... to depression and anger. Graduates showed a significant decrease ...
... 2008 The American Society for Gastrointestinal ... regarding gastrointestinal (GI) endoscopy. The guidelines note that ... the adoption of endoscope reprocessing (cleaning) guidelines. The ... issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed ...
... mechanism by which emerging daughter cells organize and divvy ... new study, researchers at the University of Illinois and ... orchestrates chromosome movements at a critical stage of cell ... the National Academy of Sciences. , Within the complex ...
... The rate of childhood,obesity in America has more ... of children ages 10 to 17 are overweight ... of the obesity epidemic for,children, families, communities and ... Healthy Florida ( http://www.bluefoundationfl.com ), the,philanthropic affiliate of ...
Cached Medicine News:Health News:Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball 2Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 2Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 3Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 4Health News:Depression and anger can plague recent university graduates: Study 2Health News:ASGE issues updated infection control guidelines for gastrointestinal endoscopy 2Health News:ASGE issues updated infection control guidelines for gastrointestinal endoscopy 3Health News:Research shines spotlight on a key player in the dance of chromosomes 2Health News:Research shines spotlight on a key player in the dance of chromosomes 3Health News:The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: